Tar Heel Times
Your comprehensive source for Tar Heel sports news

UNC ranked 7th among biomedical research institutions


Researchers at the University of North Carolina at Chapel Hill are using genetically engineered mouse models to help predict how humans will respond to different chemotherapy drug combinations used to fight breast cancer. Last year, UNC scientists identified biomarkers for challenging molecular subtypes of human breast cancer in genetically engineered mice, specifically looking for types that have few known targets and available therapies. (Fierce Biotech Research)


Related:

Share: Facebook | Twitter | Email

Recent Campus Connections News:

The Daily Tar Heel recognizes seven notable alumni for Black History Month

After leaving Steep Canyon Rangers, UNC grad and musician Charles Humphrey is blazing new trails

What are some of the Go-To Restaurants in the Chapel Hill area?

Celebrating Carolina's pioneers

UNC sports advertising researcher speaks at Winter Games in South Korea

New Performing Arts Space Opens in Carolina Square


© 2005-2018 Tar Heel Times | Contact | Privacy Policy | Site Map | RSS | Did UNC Win?

Tar Heel Times is an unofficial resource for UNC fans and is not affiliated with the University of North Carolina.